Beconase Hayfever Aq Nasal Spray Information:

NO PRESCRIPTION REQUIRED FOR BECONASE Aqueous Nasal Spray Beconase Hayerfever contains 50 Micrograms (50mcg) Beclometasone Dipropionate BP per 100mg actuation. Beconase Hayfever is indicated for the prevention and treatment of allergic rhinitis, including hayfever, in adults aged 18 and over. Beconase Aqueous Nasal Spray is indicated for the prophylaxis and treatment of perennial and seasonal allergic rhinitis including hayfever, and vasomotor rhinitis. Beclomethasone dipropionate has a potent anti-inflammatory effect within the respiratory tract, with a lower incidence and severity of adverse events than those observed when corticosteroids are administered systemically.

Beconase Hayfever Aq Nasal Spray Side Effects:

Systemic effects of nasal corticosteroids may occur particularly when used at high doses for prolonged periods. Rare cases of nasal septal perforation have been reported following the use of intranasal corticosteroids. As with other nasal sprays, dryness and irritation of the nose and throat, unpleasant taste and smell and epistaxis have been reported rarely. Rare cases of raised intraocular pressure or glaucoma in association with intranasal formulations of beclomethasone have been reported. Hypersensitivity reactions including rashes, urticaria, pruritus and erythema, and oedema of the eyes, face, lips and throat, have been reported.

Beconase Hayfever is for administration by the intranasal route only. Adults aged 18 and over: The recommended dosage is two sprays into each nostril morning and evening (400 micrograms/day). Once control has been established, it may be possible to maintain control with fewer sprays. A dosage regimen of one spray into each nostril morning and evening has been shown to be efficacious in some patients. However, should the symptoms recur, patients should revert to the recommended dosage of two sprays into each nostril morning and evening. The minimum dose should be used at which effective control of symptoms is maintained. Total daily administration should not exceed eight sprays (400 micrograms). Beconase Hayfever quickly starts to reduce inflammation and swelling in the nose. But for best effect patients should start to use Beconase Hayfever two or three days before they expect to get symptoms to prevent them from developing. For full therapeutic benefit Beconase Hayfever should be used regularly. If symptoms have not improved after 14 days treatment, medical advice must be sought. Beconase Hayfever is not recommended for children or adolescents under 18 years of age.